The Zacks Analyst Blog Highlights Apellis, Groupon and Central Garden
For Immediate Release
Chicago, IL – October 25, 2023 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Apellis Pharmaceuticals, Inc. APLS, Groupon, Inc. GRPN and Central Garden & Pet Co. CENTA.
Here are highlights from Tuesday’s Analyst Blog:
Best Momentum Plays from This List of Zacks Top-Ranked Stocks
Here are three stocks with buy ranks and strong momentum characteristics for investors to consider today:
Apellis Pharmaceuticals, Inc.: This commercial-stage biopharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 12.1% over the last 60 days.
Apellis Pharmaceuticals, Inc. price-consensus-chart | Apellis Pharmaceuticals, Inc. Quote
Apellis’ shares gained 50.3% over the last three months compared with the S&P 500’s decline of 6.8%. The company possesses a Momentum Score of A.
Apellis Pharmaceuticals, Inc. price | Apellis Pharmaceuticals, Inc. Quote
Groupon, Inc.: This marketplace which connects consumers to merchants has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 13.9% over the last 60 days.
Groupon, Inc. price-consensus-chart | Groupon, Inc. Quote
Groupon’s shares gained 67.3% over the last three months compared with the S&P 500’s decline of 6.8%. The company possesses a Momentum Score of B.
Groupon, Inc. price | Groupon, Inc. Quote
Central Garden & Pet Co.: This gardening and pet supply company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its next year earnings increasing 1.4% over the last 60 days.
Central Garden & Pet Company price-consensus-chart | Central Garden & Pet Company Quote
Central Garden’s shares gained 3.6% over the last three months compared with the S&P 500’s decline of 6.8%. The company possesses a Momentum Score of B.
Central Garden & Pet Company price | Central Garden & Pet Company Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Why Haven’t You Looked at Zacks' Top Stocks?
Since 2000, our top stock-picking strategies have blown away the S&P's +6.2 average gain per year. Amazingly, they soared with average gains of +46.4%, +49.5% and +55.2% per year. Today you can access their live picks without cost or obligation.
See Stocks Free >>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Groupon, Inc. (GRPN) : Free Stock Analysis Report
Apellis Pharmaceuticals, Inc. (APLS) : Free Stock Analysis Report
Central Garden & Pet Company (CENTA) : Free Stock Analysis Report
